Italia markets close in 1 hour 36 minutes

ILMN Jan 2025 260.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,90000,0000 (0,00%)
In data: 09:40AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,9000
Aperto0,9000
Denaro0,0000
Lettera1,5000
Prezzo d'esercizio260,00
Scadenza2025-01-17
Min-Max giorno0,9000 - 0,9000
Contratto - Min-MaxN/D
Volume6
Open Interest51
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera